{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:26:52Z","timestamp":1649093212591},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jcf.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T23:14:42Z","timestamp":1464909282000},"page":"411-412","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aminoglycosides: old friend\u2026new foe?"],"prefix":"10.1016","volume":"15","author":[{"given":"N.J.","family":"Simmonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2016.05.011_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00196314","article-title":"Europe EETFoPoCfAwCFi. Future trends in cystic fibrosis demography in 34 European countries","volume":"46","author":"Burgel","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2016.05.011_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ppul.20138","article-title":"Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use","volume":"39","author":"Al-Aloul","year":"2005","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2016.05.011_bb0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.31.4.594","article-title":"Cumulative and acute toxicity of repeated high-dose tobramycin","volume":"31","author":"Pedersen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jcf.2016.05.011_bb0020","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/jac\/dkt035","article-title":"Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis","volume":"68","author":"Alghanem","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jcf.2016.05.011_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside toxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2016.05.011_bb0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/FPC.0b013e328312b072","article-title":"Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population","volume":"18","author":"Conrad","year":"2008","journal-title":"Pharmacogenet Genomics"},{"issue":"9459","key":"10.1016\/j.jcf.2016.05.011_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis\u2014the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jcf.2016.05.011_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcf.2015.07.012","article-title":"The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison","volume":"15","author":"Prayle","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2016.05.011_bb0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcf.2015.06.005","article-title":"d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models","volume":"15","author":"Fox","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316305136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316305136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T12:53:19Z","timestamp":1536670399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199316305136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1569199316305136"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2016.05.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aminoglycosides: old friend\u2026new foe?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}